U.S. Markets closed

Kamada Ltd. (KMDA.TA)

Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
Add to watchlist
1,546.00+1.00 (+0.06%)
As of 1:04PM IDT. Market open.
Full screen
Previous Close1,545.00
Open1,545.00
Bid1,545.00 x 346500
Ask1,546.00 x 57900
Day's Range1,545.00 - 1,568.00
52 Week Range15.44 - 1,568.00
Volume7,571
Avg. Volume122,683
Market Cap614.61M
Beta1.25
PE Ratio (TTM)-6,606.84
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Associated Press18 days ago

    Kamada posts 2Q profit

    On a per-share basis, the Ness Ziona, Israel-based company said it had net income of 13 cents. Earnings, adjusted for stock option expense, came to 14 cents per share. The biopharmaceutical posted revenue ...

  • Kamada Withdraws Inhaled AAT Marketing Application in EU
    Zacks2 months ago

    Kamada Withdraws Inhaled AAT Marketing Application in EU

    Kamada Ltd.'s (KMDA) decided to withdraw the marketing authorization application (MAA) for its inhaled formulation of Alpha-1 Antitrypsin (AAT) in the EU.

  • Capital Cube2 months ago

    Kamada Ltd. – Value Analysis (TEL AVIV:KMDA) : June 16, 2017

    Categories: Europe Value Analsysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Kamada Ltd. a score of 57. Our analysis is based on comparing Kamada Ltd. with the following peers – Compugen Ltd., BioCancell Ltd., XTL Biopharmaceuticals Ltd. and RedHill Biopharma Ltd. (CGEN-IL, BICL-IL, XTLB-IL and RDHL-IL). Investment Outlook Kamada Ltd. has a fundamental score of 57 and has ... Read more (Read more...)